Startseite Naturwissenschaften Crystal structure of 2-(bis(4-methoxyphenyl)amino)-2-oxoacetic acid, C16H15NO5
Artikel Open Access

Crystal structure of 2-(bis(4-methoxyphenyl)amino)-2-oxoacetic acid, C16H15NO5

  • Gamal A. El-Hiti EMAIL logo , Keith Smith , Mesfer Alamri , Ceri A. Morris , Benson M. Kariuki und Peter Kille
Veröffentlicht/Copyright: 20. Januar 2017
Artikel downloaden (PDF)
Veröffentlichen auch Sie bei De Gruyter Brill
Manuskript einreichen Informationen für Autor*innen
Zeitschrift für Kristallographie - New Crystal Structures
Aus der Zeitschrift Zeitschrift für Kristallographie - New Crystal Structures Band 232 Heft 2

Abstract

C16H15NO5, monoclinic, P21/n (no. 14), a = 6.7689(5) Å, b = 45.219(3) Å, c = 10.1102(6) Å, β = 101.360(7)°, V = 3033.9(4) Å3, T = 298(2) K.

CCDC no.:: 1525292

Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.

Table 1

Data collection and handling.

Crystal:Colorless block
Size:0.30 × 0.22 × 0.17 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.10 mm−1
Diffractometer, scan mode:Atlas, ω
2θmax, completeness:58°, 97.3%
N(hkl)measured, N(hkl)unique, Rint:15585, 6846, 0.353
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 3929
N(param)refined:403
Programs:CrysAlisPRO [18], SHELX [19], WinGX [20], CHEMDRAW Ultra [21]
Table 2

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
C1−0.3411(7)0.26406(10)−0.1012(4)0.1293(17)
H1A−0.47160.2549−0.11780.194*
H1B−0.31710.2728−0.18310.194*
H1C−0.33590.2791−0.03360.194*
C2−0.2196(4)0.22459(6)0.0489(3)0.0588(7)
C3−0.0928(4)0.20057(6)0.0757(3)0.0633(7)
H30.00660.19750.02540.076*
C4−0.1137(4)0.18125(6)0.1767(3)0.0610(7)
H4−0.02820.16500.19430.073*
C5−0.2587(4)0.18557(5)0.2517(2)0.0477(6)
C6−0.3827(5)0.20947(7)0.2264(3)0.0724(9)
H6−0.48070.21260.27770.087*
C7−0.3637(5)0.22914(7)0.1245(3)0.0789(9)
H7−0.44890.24540.10760.095*
C8−0.3962(4)0.14275(6)0.3527(2)0.0507(6)
C9−0.5151(4)0.13514(6)0.2117(3)0.0504(6)
C10−0.1313(4)0.17106(5)0.4890(2)0.0496(6)
C110.0482(4)0.15607(6)0.5151(2)0.0576(7)
H110.07790.14240.45310.069*
C120.1853(4)0.16125(6)0.6335(3)0.0629(7)
H120.30770.15120.65100.075*
C130.1395(4)0.18131(6)0.7255(3)0.0596(7)
C14−0.0412(5)0.19644(6)0.6983(3)0.0633(7)
H14−0.07130.21010.76010.076*
C15−0.1772(4)0.19128(6)0.5798(3)0.0595(7)
H15−0.29920.20140.56160.071*
C160.4445(5)0.17124(8)0.8805(3)0.0927(11)
H16A0.41180.15060.87450.139*
H16B0.51010.17590.97110.139*
H16C0.53280.17580.81980.139*
C171.5746(4)0.04762(7)1.5043(3)0.0717(8)
H17A1.57920.03031.45010.108*
H17B1.63070.04311.59690.108*
H17C1.65120.06321.47380.108*
C181.2664(4)0.06381(5)1.3672(2)0.0468(6)

Source of material

A solution of oxalyl chloride (1 mole equivalent) in dichloromethane (DCM) was added dropwise to a solution of bis(4-methoxyphenyl)amine (1 mole equivalent) in DCM in the presence of triethylamine at room temperature. The mixture was stirred for 1.5 h and water was added. The organic layer was separated, dried over anhydrous magnesium sulfate and evaporated under reduced pressure to give the title compound in 46% yield. The low yield could be a result of half of the amine acting as a base to abstract hydrogen chloride evolved from the reaction. To investigate this issue the reaction was repeated with two equivalents of bis(4-methoxyphenyl)amine and no triethylamine. Following aqueous work-up, the crude product was obtained in 75% yield based on oxalyl chloride. Crystallization using acetonitrile gave the title compound as colorless crystals, Mp. 122–123 °C. The NMR spectra recorded at room temperature showed two sets of signals for the two aryl rings, confirming restricted rotation about the C—N bond. The barriers to free rotation in such compounds are already known to be substantial [1], [2], [3]. 1H NMR (400 MHz, DMSO-d6): δ 7.04, 6.96 (2 d, J = 8.5 Hz, 4 H, H-2/H-6), 6.86, 6.69 (2 d, J = 8.5 Hz, 4 H, H-3/H-5), 3.82, 3.71 (2 s, 6 H, OMe); 13C NMR (100 MHz, DMSO-d6): δ 164.4 (s, CO2H), 159.2 (s, C = O), 158.3 (s, C-4), 134.0, 132.8 (2 s, C-1), 129.8, 127.7 (2 d, C-2/C-6), 114.8 (2 d, C-3/C-5), 56.0, 55.8 (2 q, OMe); ES+−MS: m/z (%) 302 (MH+, 100), 288 (12), 256 (21), 228 (12); HRMS (ES+): calculated for C16H16NO5 (MH+): 302.1028; found: 302.1028. IR (FT): νmax 3300, 1740, 1713, 1665, 1500, 1366, 1167 cm−1.

Experimental details

Non-hydrogen atoms were refined with anisotropic displacement parameters. All hydrogen atoms were placed in calculated positions and refined using a ring model. Methyl C—H bonds were fixed at 0.96 Å and displacement parameters were 1.5 times Ueq(C). The methyl groups were allowed to spin about the C—C bond. Aromatic C—H distances were set to 0.93 Å and their U(iso) parameters were set to 1.2 times Ueq(C). Hydroxyl O—H distances were set to 0.82 Å and their U(iso) set to 1.5 times Ueq(O). Crystal data, data collection and structure refinement details are summarized in Table 1.

Comment

Aryl oxamic acid derivatives have various interesting applications [4], [5], [6], [7], [8]. In addition, aryl oxamic acids can be used as intermediates for the synthesis of various classes of compounds including heterocycles [9], [10], [11], [12]. Oxamates can be synthesized by the use of various synthetic procedures [13], [14], [15], [16], [17].

In the title crystal structure, the asymmetric unit consists of two independent molecules of C16H15NO5. The oxoacetic acid fragments of the molecule are involved in intermolecular hydrogen bonding, of the type O—H⋯O, with the following geometric parameters: O4⋯O7 = 2.673(2) Å, O—H⋯O = 171.0°; and O9⋯O2 = 2.734(2) Å, O—H⋯O = 169.9° forming chains along [101].

These hydrogen bonds can be classified as medium strong. Bond lengths and angles in both crystallographically independent molecules are in the expected ranges.

Acknowledgement

We thank the EPSRC for the grant which supplied the MS instrumentation used in this study. M. Alamri thanks the Saudi Cultural Bureau, London for a scholarship and G. A. El-Hiti extends his appreciation to the Deanship of Scientific Research at King Saud University for its funding for this research through the research group project RGP-239.

References

1 Hobson, R. F.; Reeves, L. W.: Hindered rotation about the N-C bond in some vinylogous amides. J. Magn. Reson. 10 (1973) 243–252.10.1016/0022-2364(73)90247-3Suche in Google Scholar

2 Smith, B. D.; Goodenough-Lashua, D. M.; D’Souza, C. J. E.; Norton, K. J.; Schmidt, L. M.; Tung, J. C.: Substituent effects on the barrier to carbamate C–N rotation. Tetrahedron Lett. 45 (2004) 2747–2749.10.1016/j.tetlet.2004.02.037Suche in Google Scholar

3 Krishnan, V. V.; Thompson, W. B.; Goto, J. J.; Maitra, K.; Maitra, S.: Modulations in restricted amide rotation by steric induced conformational trapping. Chem. Phys. Lett. 523 (2012) 124–127.10.1016/j.cplett.2011.11.058Suche in Google Scholar PubMed PubMed Central

4 Maiore, L.; Aragoni, M. C.; Carcangiu, G.; Cocco, O.; Isaia, F.; Lippolis, V.; Meloni, P.; Murru, A.; Slawin, A. M. Z.; Tuveri, E.; Woollins, J. D.; Arca, M.: Oxamate salts as novel agents for the restoration of marble and limestone substrates: case study of ammonium N-phenyloxamate. New J. Chem. 40 (2016) 2768–2774.10.1039/C5NJ02505BSuche in Google Scholar

5 Miskimins, W. K.; Ahn, H. J.; Kim, J. Y.; Ryu, S.; Jung, Y.-S.; Choi, J. Y.: Synergistic anti-cancer effect of phenformin and oxamate. PLOS One 9 (2014) e85576, doi: 10.1371/journal.pone.0085576.10.1371/journal.pone.0085576Suche in Google Scholar PubMed PubMed Central

6 Choi, S.-R.; Beeler, A. B.; Pradhan, A.; Watkins, E. B.; Rimoldi, J. M.; Tekwani, B.; Avery, M. A.: Generation of oxamic acid libraries: antimalarials and inhibitors of plasmodium falciparum lactate dehydrogenase. J. Comb. Chem. 9 (2007) 292–300.10.1021/cc060110nSuche in Google Scholar PubMed

7 Hargrave, K. D.; Hess, F. K.; Oliver, J. T.: N-(4-Substituted-thiazolyl)oxamic acid derivatives, new series of potent, orally active antiallergy agents. J. Med. Chem. 26 (1983) 1158–1163.10.1021/jm00362a014Suche in Google Scholar PubMed

8 Klaubert, D. H.; Sellstedt, J. H.; Guinosso, C. J.; Capetola, R. J.; Bell, S. C.: N-(Aminophenyl)oxamic acids and esters as potent, orally active antiallergy agents. J. Med. Chem. 24 (1981) 742–748.10.1021/jm00138a020Suche in Google Scholar PubMed

9 Wang, H.; Guo, L.-N.; Wang, S.; Duan, X.-H.: Decarboxylative alkynylation of a-keto acids and oxamic acids in aqueous media. Org. Lett. 17 (2015) 3054–3057.10.1021/acs.orglett.5b01336Suche in Google Scholar PubMed

10 Loloiu, G.; Maior, O.: Isatin chemistry. Synthesis of N-methyl-2, 3-dioxo-2,3-dihydropyrrolo(2, 3-b) phenoxathiin. Rev. Roum. Chim. 42 (1997) 67–69.10.1002/chin.199745166Suche in Google Scholar

11 Molina, P.; Vilaplana, M. J.; Andreu, P. L.; Moller, J.: Oxamic acid derivatives in heterocyclic synthesis: preparation of 1,2,4-triazolo[1,5-a]pyrazine derivatives. J. Heterocycl. Chem. 24 (1984) 1281–1284.10.1002/chin.198815243Suche in Google Scholar

12 Downs, J. R.; Pastine, S. J.; Schady, D. A.; Greer, H. A.; Kelley, W.; Embree, M. C.; Townsend, J. D.; Beam, C. F.: Preparation of 1H-pyrazole-5-carboxamides from dilithiated C(α),N-phenylhydrazones and lithiated ethyl oxanilates or lithiated ethyl oxamate. J. Heterocycl. Chem. 38 (2001) 691–694.10.1002/jhet.5570380325Suche in Google Scholar

13 Gadge, S. T.; Kusumawati, E. N.; Harada, K.; Sasaki, T.; Nishio-Hamane, D.; Bhanage, B. M.: Synthesis of oxamate and urea by oxidative single and double carbonylation of amines using immobilized palladium metal-containing ionic liquid@SBA-15. J. Mol. Catal. A: Chem. 400 (2015) 170–178.10.1016/j.molcata.2015.01.009Suche in Google Scholar

14 Gadge, S. T.; Bhanage, B. M.: Pd/C-Catalyzed synthesis of oxamates by oxidative cross double carbonylation of amines and alcohols under Co-catalyst, base, dehydrating agent, and ligand-free conditions. J. Org. Chem. 78 (2013) 6793–6797.10.1021/jo401038eSuche in Google Scholar PubMed

15 Lisnard, L.; Chamoreau, L.-M.; Li, Y.; Journaux, Y.: Solvothermal synthesis of oxamate-based helicate: temperature dependence of the hydrogen bond structuring in the solid. Cryst. Growth Des. 12 (2012) 4955–4962.10.1021/cg300877rSuche in Google Scholar

16 Yang, G.; Zhang, H.; Huang, Y.; Chen, Z.: Synthesis of methyl N-aryl oxamate using soluble polymer support. Synth. Commun. 36 (2006) 611–619.10.1080/00397910500408357Suche in Google Scholar

17 Lesimple, P.; Bigg, D. C. H.: An improved procedure for the preparation of alkyl N-(4-aryl-2-thiazolyl)oxamates. Synthesis 1991(9) (1991) 763–764.10.1055/s-1991-26569Suche in Google Scholar

18 Agilent. CrysAlisPRO. Agilent Technologies, Yarnton, England, 2014.Suche in Google Scholar

19 Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar PubMed

20 Farrugia, L. J.: WinGX and ORTEP for Windows: an update. J. Appl. Crystallogr. 45 (2012) 849–854.10.1107/S0021889812029111Suche in Google Scholar

21 Cambridge Soft. CHEMDRAW Ultra. Cambridge Soft Corporation, Cambridge, MA, USA, 2001.Suche in Google Scholar

Received: 2016-10-17
Accepted: 2017-1-3
Published Online: 2017-1-20
Published in Print: 2017-3-1

©2017 Gamal A. El-Hiti et al., published by De Gruyter.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. The crystal structure of triphenylphosphineoxide – 2,5-dichloro-3,6-dihydroxycyclohexa-2,5-diene-1,4-dione (2/1), C42H32Cl2O6P2
  3. Crystal structure of poly-[diaqua-[bis(μ2-hydroxy)-bis(μ4-3,4,5,6-tetrachlorophthalato-κ3O,O′:O′; κ2O′′:O′′′)dilanthanum(III)], C8H3Cl4LaO6
  4. Crystal structure of 1,1′-(3,4-diphenylthieno[2,3-b]thiophene-2,5-diyl)bis[1-phenyl-methanone], C32H20O2S2
  5. Crystal structure of 4a-hydroxy-9-(3,5-dibromo-phenyl)-3,4,4a,5,6,7,9,9a-octahydro-2H-xanthene-1,8-dione, C19H18Br2O4
  6. Crystal structure of 5-hydroxy-4,6,9,10-tetramethyl-1-oxo-6-vinyldecahydro-3a,9-propanocyclopenta[8]annulen-8-yl 2-((2-methyl-1-(3-methylbenzamido)propan-2-yl)thio)acetate, C34H49NO5S
  7. Crystal structure of pyridinium bis(naphthalane-2,3-diolato-κ2O,O′)borate monohydrate, C25H20BNO5
  8. Crystal structure of 1,1′-((1E,1′E)-(((ethane-1,2-diylbis(oxy))bis(2,1-phenylene))bis(azanylylidene))bis(methanylylidene))bis(naphthalen-2-olato)nickel(II), C72H52N4O8Ni2
  9. The crystal structure of 3-(2-acetyl-4-butyramido-phenoxy)-2-hydroxy-N-isopropylpropan-1-aminium tetraphenylborate, C42H49BN2O4
  10. Crystal structure of 4-bromobenzyl (Z)-N′-(adamantan-1-yl)-4-phenylpiperazine-1-carbothioimidate, C28H34BrN3S
  11. Crystal structure of poly-[(μ6-benzene-1,2,4,5-tetracarboxylato)-(μ2-1,2-bis(imidazol-1-ylmethyl)benzene)dicobalt(II)], Co2C24H16N4O8
  12. Crystal structure of catena-(bis(μ2-1, 2-bis(imidazole-1-ylmethyl)benzene-κN:N′)-dichlororido-nickel(II)), C28H28Cl2N8Ni
  13. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxy-3-(4-methoxyphenyl)prop-2-en-1-one, C15H16N2O3
  14. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxy-3-phenylprop-2-en-1-one, C14H14N2O2
  15. Crystal structure of (E)-2-(4-hydroxy-3-methoxybenzylidene)-6-methoxy-3,4-dihydronaphthalen-1(2H)-one, C19H18O4
  16. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-(4-ethoxyphenyl)-3-hydroxyprop-2-en-1-one, C16H18N2O3
  17. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxy-3-(p-toly)prop-2-en-1-one, C15H16N2O2
  18. Crystal structure of 1-acetyl-3-(3-chlorophenyl)-5-(4-isopropylphenyl)-4,5-dihydro-(1H)-pyrazole, C20H21ClN2O
  19. The crystal structure of 1-methyl-2,4-dinitro-5-iodoimidazole, C4H3IN4O4
  20. The crystal structure of 4-chloro-3,5-dinitroaniline, C6H4ClN3O4
  21. Crystal structure of N,N-dimethyl-N′-(2-methyl-4-oxo-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-3(4H)-yl)formimidamide, C14H18N4OS
  22. Crystal structure of tetrakis(μ2-acetato-κ2O:O′)-bis[μ3-4-chloro-2,6-bis((methylimino)methyl)phenolato-κ2N,O:O,N′]-(μ4-oxido)tetracopper(II), C28H32Cl2Cu4N4O11
  23. Crystal structure of catena-poly[diaqua-bis(μ2-ethane-1,2-diyl-bis(pyridine-3-carboxylate-κ2N:N′))copper(II)] dinitrate, C28H28CuN6O16
  24. Synthesis and crystal structure of catena-poly[(μ2-nicotinato-κ2O,O′: κ1N)-(nitrato-κ1O)-(bis(2-benzimidazol-ylmethyl)amine-κ3N,N′,N′′)lead(II)], C22H18N7O5Pb
  25. The twinned crystal structure of (4SR)-7-benzyl-2,4,8,8-tetramethyl-7,8-dihydroimidazo[5,1-c][1,2,4]triazine-3,6(2H,4H)-dione, C16H20N4O2
  26. Crystal structure of (Z)-3-hydroxy-3-(4-methoxyphenyl)-1-(pyridin-2-yl)prop-2-en-1-one, C15H13NO3
  27. Crystal structure of 2-amino-4-(2,3-dichlorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C16H12Cl2N2O2
  28. Crystal structure of catena-poly[(μ2-butane-1,4-diyl-bis(pyridine-3-carboxylato-κN))silver(I)] tetrafluoroborate, C16H16AgN2O4BF4
  29. Crystal structure of poly[diaqua-(1,10-phenanthroline-κ2N,N′)-(μ2-2,5-dihydroxytere-phthalato)-bis(μ4-2,5-dihydroxyterephthalato)dicerium(III)], C24H16CeN2O10
  30. Crystal structure of 5,7,4′-trihydroxy-3,8,3′-trymethoxyflavone, C18H16O8
  31. Crystal structure of N-(3,4-dichlorobenzylidene)-4-methylaniline, C14H11Cl2N
  32. Crystal structure of 4-(3-Methoxy-phenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylic acid ethyl ester, C22H27NO4
  33. Crystal structure of 2-amino-4-(3-fluorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C16H13FN2O2
  34. Crystal structure of 1,1,(3,4-dihydroxythieno[2,3-b] thiophene-2,5-diyl)bis(2-bromoethanone), C10H6Br2O4S2
  35. The crystal structure of N,N′-(4,4′-oxydibenzyl)-bisisonicotinamide 3.5 hydrate, C24H24N4O6
  36. Crystal structure of catena-poly[hexakis(μ2-chlorido)-hexakis(4-(1H-pyrazol-5-yl)pyridine-κN)tricadmium(II)], Cd3C48H42Cl6N18
  37. Crystal structure of 2-(4-(dimethylamino)phenyl)-1,3-dimethyl-1H-perimidin-3-ium iodide, C21H22I1N3
  38. Crystal structure of 4-(1,3-dimethyl-2,3-dihydro-1H-perimidin-2-yl)benzonitrile, C20H17N3
  39. Crystal structure of tetrakis(μ2-acetato-κ2O:O′)-bis(2,2′-sulfonyldipyrazine-κ1N)dicopper(II), C24H24Cu2N8O12S2
  40. Crystal structure of 1-(4-chlorophenyl)-6,8-diphenyl-1H-pyrazolo[4,3-c]quinoline, C28H18ClN3
  41. Crystal structure of methyl 3-((1-(2-(methoxycarbonyl)benzyl)-1H-1,2,3-triazol-4-yl)methoxy)-2-naphthoate, C24H21N3O5
  42. Crystal structure of (tris(2-pyridylmethyl)amine-κ4N,N′,N′′,N′′′′)-chloranilato-κO,O′-zinc(II) – methanol (1/1), C25H22Cl2N4O5Zn
  43. Crystal structure of 1,1-dimethyl-3-(4-methoxyphenyl)urea, C10H14N2O2
  44. Crystal structure of 4a-Hydroxy-9-(2-nitro-phenyl)-3,4,4a,5,6,7,9,9a-octahydro-2H-xanthene-1,8-dione, C19H19NO6
  45. Crystal structure of chlorido-(η6–1-isopropyl-4-methyl benzene)-(1-(pyridin-2-yl)-N-(p-tolyl)methanimine-κ2N,N′)ruthenium(II) hexafluorophosphate(V), C23H26ClF6N2PRu
  46. Crystal structure of phenyl(2-phenyl-2,3-dihydro-1H-perimidin-2-yl)methanone, C24H18N2O
  47. Crystal structure of (E)-3-methyl-4-((3-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)methylene)-1-phenyl-1H-pyrazol-5(4H)-one, C29H23N7O
  48. Crystal structure of 2-(4-(2-butyl-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)piperazin-1-yl)-2-oxoethyldiethylcarbamodithioate, C27H34N4O3S2
  49. Crystal structure of poly-[diaqua-bis(μ-4,4′-bipyridine-κ2N:N′)cobalt(II)] bis(4-chlorobenzenesulfonate) – 4,4′-bipyridine – water (1/1/2), C42H40Cl2CoN6O10S2
  50. Crystal structure of (η6-benzene)-(N-(2,6-dimethylphenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)ruthenium(II) perchlorate monohydrate, C20H20Cl2N2O5Ru
  51. Crystal structure of 4,10,16,22-tetrahydroxy-6,12,18,24-tetramethoxy-2,8,14,20-tetraethylphenylresorcin[4]arene – ethyl acetate (1/1), C68H72O10
  52. Crystal structure of chlorido-(N-(2,5-dichlorophenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)(η6-1-isopropyl-4-methyl benzene) ruthenium (II) tetrafluoroborate, C22H22Cl3N2BF4Ru
  53. Crystal structure of 3-(5-methyl-1-p-tolyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde, a rare Z′ = 3 structure, C20H17N5O
  54. Crystal structure of 5-(5-(4-chlorophenyl)-1-phenyl-1H-pyrazol-3-yl)-N-phenyl-1,3,4-thiadiazol-2-amine, C23H16ClN5S
  55. Crystal structure of 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one-N,N-dimethylformamide (1/1), C18H17NO5
  56. Crystal structure of halogen-bonded 2-chloro-1,10-phenanthroline—1,4-diiodotetrafluorobenzene (2/1), C30H14Cl2F4I2N4
  57. Crystal structure of 1-(4,4-dimethyl-2,6-dithioxo-1,3,5-triazinan-1-yl)-3-(diethylaminocarbonyl)thiourea, C11H20N6OS3
  58. Crystal structure of methyl 1-(4-fluorobenzyl)-3-phenyl-1H-pyrazole-5-carboxylate, C18H15FN2O2
  59. Crystal structure of 1,1-dimethyl-3-(4-methylphenyl)urea, C10H14N2O
  60. Crystal structure of yttrium gallium antimonide, Y5Ga1.24Sb2.77
  61. Crystal structure of 2-(bis(4-methoxyphenyl)amino)-2-oxoacetic acid, C16H15NO5
https://doi.org/10.1515/ncrs-2016-0325
Creative Commons
BY-NC-ND 3.0

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. The crystal structure of triphenylphosphineoxide – 2,5-dichloro-3,6-dihydroxycyclohexa-2,5-diene-1,4-dione (2/1), C42H32Cl2O6P2
  3. Crystal structure of poly-[diaqua-[bis(μ2-hydroxy)-bis(μ4-3,4,5,6-tetrachlorophthalato-κ3O,O′:O′; κ2O′′:O′′′)dilanthanum(III)], C8H3Cl4LaO6
  4. Crystal structure of 1,1′-(3,4-diphenylthieno[2,3-b]thiophene-2,5-diyl)bis[1-phenyl-methanone], C32H20O2S2
  5. Crystal structure of 4a-hydroxy-9-(3,5-dibromo-phenyl)-3,4,4a,5,6,7,9,9a-octahydro-2H-xanthene-1,8-dione, C19H18Br2O4
  6. Crystal structure of 5-hydroxy-4,6,9,10-tetramethyl-1-oxo-6-vinyldecahydro-3a,9-propanocyclopenta[8]annulen-8-yl 2-((2-methyl-1-(3-methylbenzamido)propan-2-yl)thio)acetate, C34H49NO5S
  7. Crystal structure of pyridinium bis(naphthalane-2,3-diolato-κ2O,O′)borate monohydrate, C25H20BNO5
  8. Crystal structure of 1,1′-((1E,1′E)-(((ethane-1,2-diylbis(oxy))bis(2,1-phenylene))bis(azanylylidene))bis(methanylylidene))bis(naphthalen-2-olato)nickel(II), C72H52N4O8Ni2
  9. The crystal structure of 3-(2-acetyl-4-butyramido-phenoxy)-2-hydroxy-N-isopropylpropan-1-aminium tetraphenylborate, C42H49BN2O4
  10. Crystal structure of 4-bromobenzyl (Z)-N′-(adamantan-1-yl)-4-phenylpiperazine-1-carbothioimidate, C28H34BrN3S
  11. Crystal structure of poly-[(μ6-benzene-1,2,4,5-tetracarboxylato)-(μ2-1,2-bis(imidazol-1-ylmethyl)benzene)dicobalt(II)], Co2C24H16N4O8
  12. Crystal structure of catena-(bis(μ2-1, 2-bis(imidazole-1-ylmethyl)benzene-κN:N′)-dichlororido-nickel(II)), C28H28Cl2N8Ni
  13. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxy-3-(4-methoxyphenyl)prop-2-en-1-one, C15H16N2O3
  14. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxy-3-phenylprop-2-en-1-one, C14H14N2O2
  15. Crystal structure of (E)-2-(4-hydroxy-3-methoxybenzylidene)-6-methoxy-3,4-dihydronaphthalen-1(2H)-one, C19H18O4
  16. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-(4-ethoxyphenyl)-3-hydroxyprop-2-en-1-one, C16H18N2O3
  17. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxy-3-(p-toly)prop-2-en-1-one, C15H16N2O2
  18. Crystal structure of 1-acetyl-3-(3-chlorophenyl)-5-(4-isopropylphenyl)-4,5-dihydro-(1H)-pyrazole, C20H21ClN2O
  19. The crystal structure of 1-methyl-2,4-dinitro-5-iodoimidazole, C4H3IN4O4
  20. The crystal structure of 4-chloro-3,5-dinitroaniline, C6H4ClN3O4
  21. Crystal structure of N,N-dimethyl-N′-(2-methyl-4-oxo-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-3(4H)-yl)formimidamide, C14H18N4OS
  22. Crystal structure of tetrakis(μ2-acetato-κ2O:O′)-bis[μ3-4-chloro-2,6-bis((methylimino)methyl)phenolato-κ2N,O:O,N′]-(μ4-oxido)tetracopper(II), C28H32Cl2Cu4N4O11
  23. Crystal structure of catena-poly[diaqua-bis(μ2-ethane-1,2-diyl-bis(pyridine-3-carboxylate-κ2N:N′))copper(II)] dinitrate, C28H28CuN6O16
  24. Synthesis and crystal structure of catena-poly[(μ2-nicotinato-κ2O,O′: κ1N)-(nitrato-κ1O)-(bis(2-benzimidazol-ylmethyl)amine-κ3N,N′,N′′)lead(II)], C22H18N7O5Pb
  25. The twinned crystal structure of (4SR)-7-benzyl-2,4,8,8-tetramethyl-7,8-dihydroimidazo[5,1-c][1,2,4]triazine-3,6(2H,4H)-dione, C16H20N4O2
  26. Crystal structure of (Z)-3-hydroxy-3-(4-methoxyphenyl)-1-(pyridin-2-yl)prop-2-en-1-one, C15H13NO3
  27. Crystal structure of 2-amino-4-(2,3-dichlorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C16H12Cl2N2O2
  28. Crystal structure of catena-poly[(μ2-butane-1,4-diyl-bis(pyridine-3-carboxylato-κN))silver(I)] tetrafluoroborate, C16H16AgN2O4BF4
  29. Crystal structure of poly[diaqua-(1,10-phenanthroline-κ2N,N′)-(μ2-2,5-dihydroxytere-phthalato)-bis(μ4-2,5-dihydroxyterephthalato)dicerium(III)], C24H16CeN2O10
  30. Crystal structure of 5,7,4′-trihydroxy-3,8,3′-trymethoxyflavone, C18H16O8
  31. Crystal structure of N-(3,4-dichlorobenzylidene)-4-methylaniline, C14H11Cl2N
  32. Crystal structure of 4-(3-Methoxy-phenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylic acid ethyl ester, C22H27NO4
  33. Crystal structure of 2-amino-4-(3-fluorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C16H13FN2O2
  34. Crystal structure of 1,1,(3,4-dihydroxythieno[2,3-b] thiophene-2,5-diyl)bis(2-bromoethanone), C10H6Br2O4S2
  35. The crystal structure of N,N′-(4,4′-oxydibenzyl)-bisisonicotinamide 3.5 hydrate, C24H24N4O6
  36. Crystal structure of catena-poly[hexakis(μ2-chlorido)-hexakis(4-(1H-pyrazol-5-yl)pyridine-κN)tricadmium(II)], Cd3C48H42Cl6N18
  37. Crystal structure of 2-(4-(dimethylamino)phenyl)-1,3-dimethyl-1H-perimidin-3-ium iodide, C21H22I1N3
  38. Crystal structure of 4-(1,3-dimethyl-2,3-dihydro-1H-perimidin-2-yl)benzonitrile, C20H17N3
  39. Crystal structure of tetrakis(μ2-acetato-κ2O:O′)-bis(2,2′-sulfonyldipyrazine-κ1N)dicopper(II), C24H24Cu2N8O12S2
  40. Crystal structure of 1-(4-chlorophenyl)-6,8-diphenyl-1H-pyrazolo[4,3-c]quinoline, C28H18ClN3
  41. Crystal structure of methyl 3-((1-(2-(methoxycarbonyl)benzyl)-1H-1,2,3-triazol-4-yl)methoxy)-2-naphthoate, C24H21N3O5
  42. Crystal structure of (tris(2-pyridylmethyl)amine-κ4N,N′,N′′,N′′′′)-chloranilato-κO,O′-zinc(II) – methanol (1/1), C25H22Cl2N4O5Zn
  43. Crystal structure of 1,1-dimethyl-3-(4-methoxyphenyl)urea, C10H14N2O2
  44. Crystal structure of 4a-Hydroxy-9-(2-nitro-phenyl)-3,4,4a,5,6,7,9,9a-octahydro-2H-xanthene-1,8-dione, C19H19NO6
  45. Crystal structure of chlorido-(η6–1-isopropyl-4-methyl benzene)-(1-(pyridin-2-yl)-N-(p-tolyl)methanimine-κ2N,N′)ruthenium(II) hexafluorophosphate(V), C23H26ClF6N2PRu
  46. Crystal structure of phenyl(2-phenyl-2,3-dihydro-1H-perimidin-2-yl)methanone, C24H18N2O
  47. Crystal structure of (E)-3-methyl-4-((3-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)methylene)-1-phenyl-1H-pyrazol-5(4H)-one, C29H23N7O
  48. Crystal structure of 2-(4-(2-butyl-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)piperazin-1-yl)-2-oxoethyldiethylcarbamodithioate, C27H34N4O3S2
  49. Crystal structure of poly-[diaqua-bis(μ-4,4′-bipyridine-κ2N:N′)cobalt(II)] bis(4-chlorobenzenesulfonate) – 4,4′-bipyridine – water (1/1/2), C42H40Cl2CoN6O10S2
  50. Crystal structure of (η6-benzene)-(N-(2,6-dimethylphenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)ruthenium(II) perchlorate monohydrate, C20H20Cl2N2O5Ru
  51. Crystal structure of 4,10,16,22-tetrahydroxy-6,12,18,24-tetramethoxy-2,8,14,20-tetraethylphenylresorcin[4]arene – ethyl acetate (1/1), C68H72O10
  52. Crystal structure of chlorido-(N-(2,5-dichlorophenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)(η6-1-isopropyl-4-methyl benzene) ruthenium (II) tetrafluoroborate, C22H22Cl3N2BF4Ru
  53. Crystal structure of 3-(5-methyl-1-p-tolyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde, a rare Z′ = 3 structure, C20H17N5O
  54. Crystal structure of 5-(5-(4-chlorophenyl)-1-phenyl-1H-pyrazol-3-yl)-N-phenyl-1,3,4-thiadiazol-2-amine, C23H16ClN5S
  55. Crystal structure of 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one-N,N-dimethylformamide (1/1), C18H17NO5
  56. Crystal structure of halogen-bonded 2-chloro-1,10-phenanthroline—1,4-diiodotetrafluorobenzene (2/1), C30H14Cl2F4I2N4
  57. Crystal structure of 1-(4,4-dimethyl-2,6-dithioxo-1,3,5-triazinan-1-yl)-3-(diethylaminocarbonyl)thiourea, C11H20N6OS3
  58. Crystal structure of methyl 1-(4-fluorobenzyl)-3-phenyl-1H-pyrazole-5-carboxylate, C18H15FN2O2
  59. Crystal structure of 1,1-dimethyl-3-(4-methylphenyl)urea, C10H14N2O
  60. Crystal structure of yttrium gallium antimonide, Y5Ga1.24Sb2.77
  61. Crystal structure of 2-(bis(4-methoxyphenyl)amino)-2-oxoacetic acid, C16H15NO5
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2026 De Gruyter Brill
Heruntergeladen am 20.1.2026 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2016-0325/html?lang=de
Button zum nach oben scrollen